Sandrine Gazaignes

Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy

Jean‐Marc Lacombe, François Boué, Sophie Grabar et al. · AIDS · 2012 · 26 citations · Full text

Public Health, Immunology, Infectious Diseases +11

Mycoplasma pneumoniae infection in adult inpatients during the 2023–24 outbreak in France (MYCADO): a national, retrospective, observational study

Ariane Gavaud, Antoine Asquier-Khati, Karine Faure et al. · The Lancet Infectious Diseases · 2025 · 25 citations · Full text

Public Health, Clinical Sciences, Infectious Diseases +15

Pharmacokinetic Study of Raltegravir in HIV-Infected Patients With End-Stage Liver Disease: The LIVERAL-ANRS 148 Study

Caroline Barau, Joséphine Braun, Corine Vincent et al. · Clinical Infectious Diseases · 2014 · 21 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Efficacy and Safety of a Switch to Rilpivirine-Based Regimens in Treatment-Experienced HIV-1-Infected Patients: A Cohort Study

Sandrine Gazaignes, Matthieu Resche‐Rigon, Caroline Gatey et al. · Antiviral Therapy · 2015 · 14 citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +15

Molecular characterization of the 17D-204 yellow fever vaccine

Maud Salmona, Sandrine Gazaignes, Séverine Mercier‐Delarue et al. · Vaccine · 2015 · 12 citations

Veterinary Medicine, Immunology, Molecular Biology +14